Xylo Bio

📍 Boulder, United States👥 31 employees💰 Last funded Apr 2024
Biotechnology🌐 xylo.bio
Website LinkedIn
XYLO is pioneering neuroplastogens – next-generation therapeutics designed to rewire neural circuits and restore brain function. Combining advanced neuroscience with computational drug discovery, we are developing optimized treatments to revolutionize care for neurological and psychiatric conditions. Our mission is to deliver breakthrough therapies that address critical unmet needs and improve the lives of patients worldwide.
7
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Australia
4
United States
2
New Zealand
1
Investor activity2021–2024 · investors recorded per year
202112022520241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Xylo Bio?
Xylo Bio has 7 investors on record on gritt.io.
When did Xylo Bio last raise funding?
The most recent investment in Xylo Bio recorded on gritt.io was in April 2024.
What industry is Xylo Bio in?
Xylo Bio operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Xylo Bio based?
Xylo Bio is headquartered in Boulder, United States.